ABSTRACT
The fungal genus Stemphylium (phylum Ascomycota, teleomorph Pleospora) includes plant pathogenic, endophytic, and saprophytic species with worldwide distributions. Stemphylium spp. produce prodigious numbers of airborne spores, so are a human health concern as allergens. Some species also produce secondary metabolites, such as glucosides, ferric chelates, aromatic polyketides, and others, that function as toxins that damage plants and other fungal species. Some of these compounds also exhibit a low level of mammalian toxicity. The high production of airborne spores by this genus can result in a high incidence of human exposure. Concern about toxin production appears to be the reason that Stemphylium vesicarium, which is a pathogen of several vegetable crops, was classified in Canada as a potential risk of harm to humans for many years. A detailed assessment of the risk of exposure was provided to the relevant regulatory body, the Public Health Agency of Canada, which then determined that Stemphylium spp. in nature or under laboratory conditions posed little to no risk to humans or animals, and the species was re-assigned as a basic (level 1) risk agent.
Subject(s)
Ascomycota/metabolism , Ascomycota/pathogenicity , Allergens/metabolism , Allergens/toxicity , Canada , Humans , Mycotoxins/metabolism , Mycotoxins/toxicity , Plant Diseases/microbiology , Risk Assessment , Secondary Metabolism , Spores, Fungal/metabolism , Spores, Fungal/pathogenicityABSTRACT
Cardiovascular mortality in patients with chronic kidney disease remains a major problem. The uremic toxins among which the molecules of middle molecular weight are counted contribute significantly to this high mortality, alongside the traditional risk factors. They generate and maintain a chronic inflammatory state called low-level chronic inflammatory state. A growing interest in these molecules has been noted for some years and the uremic toxins associated with this cardiovascular mortality are currently identified: FGF23, cytokines, pentraxin-3 and recently light chains. The existence of an interaction between uremic toxins, inflammation and/or oxidative stress and cardiovascular mortality is well reported in the various epidemiological studies. While the use of anti-oxidative therapies and/or antibodies against uremic toxins or their site of action have not yet yielded a real benefit, hopes are turning to the use of new hemodialysis membranes medium cut-off (MCO), which have the advantage of purifying the uremic toxin middle molecules without a significant loss of albumin. However, additional works are needed to demonstrate the use of these membranes will lead to modulate the morbi-mortality in the dialysis patients.
Subject(s)
Cardiovascular Diseases/complications , Kidney Failure, Chronic/complications , Toxins, Biological/blood , Fibroblast Growth Factor-23 , Fibroblast Growth Factors/blood , Humans , Immunoglobulin Light Chains/blood , Inflammation/etiology , Inflammation/prevention & control , Interleukin-6/blood , Kidney Failure, Chronic/therapy , Membranes, Artificial , Renal Dialysis , Tumor Necrosis Factor-alpha/blood , Uremia/complications , beta 2-Microglobulin/bloodABSTRACT
Hemolytic uremic syndrome is a rare disease, frequently responsible for renal insufficiency in children. Recent findings have led to renewed interest in this pathology. The discovery of new gene mutations in the atypical form of HUS and the experimental data suggesting the involvement of the complement pathway in the typical form, open new perspectives for treatment. This review summarizes the current state of knowledge on both typical and atypical hemolytic uremic syndrome pathophysiology and examines new perspectives for treatment.
Subject(s)
Hemolytic-Uremic Syndrome/physiopathology , Animals , Anti-Bacterial Agents/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Bacterial Infections/complications , Bacterial Toxins/adverse effects , Clinical Trials as Topic , Complement System Proteins/physiology , Disease Models, Animal , Drug Evaluation, Preclinical , Escherichia coli Infections/complications , Escherichia coli Infections/microbiology , Forecasting , Genetic Predisposition to Disease , Hemolytic-Uremic Syndrome/classification , Hemolytic-Uremic Syndrome/etiology , Hemolytic-Uremic Syndrome/genetics , Hemolytic-Uremic Syndrome/microbiology , Hemolytic-Uremic Syndrome/therapy , Humans , Kidney Transplantation , Liver Transplantation , Mice , Papio , Plasma , Plasma Substitutes , Shiga Toxin/adverse effects , Shiga-Toxigenic Escherichia coli/immunology , Shiga-Toxigenic Escherichia coli/pathogenicity , Thrombophilia/etiology , Vascular Endothelial Growth Factor A/therapeutic useABSTRACT
INTRODUCTION: An outbreak of shiga-toxin producing Escherichia coli infections occurred in southwest France in June 2012. The outbreak was investigated to identify the source of infection, and guide control measures. METHODS: Confirmed outbreak cases were patients who developed bloody diarrhoea or haemolytic uremic syndrome (HUS) between 28 May and 6 July 2012, with E. coli O157 isolates showing indistinguishable patterns on pulse field gel electrophoresis (PFGE). A standardized questionnaire was administered to patients to document food consumption and other risk exposures. Their purchase was checked through their supermarket shopper card data. RESULTS: Six patients (four with HUS and two with bloody diarrhea) were confirmed outbreak cases. Fresh ground beef burgers from one supermarket were the only common food exposure, identified by interviews and shopper card data. The PFGE profile of shiga toxin-producing E. coli O157 isolated from the suspected beef burgers was identical to those from the human cases. The suspected beef burgers were no longer on sale at the time of investigation but three patients confirmed as outbreak cases had deep-frozen some at home. CONCLUSION: Shopper card data was particularly useful to obtain precise and reliable information on the traceability of consumed food. Despite the expired use-by date, a recall was issued for the beef burgers. This contributed to preventing other cases among consumers who had deep-frozen the beef burgers.